Kuriakose Emil
- SEC CIK
- 0001892413
In the past year, 3 open-market sale filings worth $101.7K and no purchases.
Current role at each company
- TERN Terns Pharmaceuticals, Inc.Chief Medical Officeras of May 5, 2026
- CALA Calithera Biosciences, Inc.CHIEF MEDICAL OFFICERas of Jan 25, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $101.7K
- 3 filings
- Net
- −$101.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kuriakose Emil as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TERN Terns Pharmaceuticals, Inc.
Chief Medical Officer6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2026 (view filing) | Apr 1 | 1 day | Kuriakose EmilChief Medical Officer | SSale | −942 | $52.75 | −$49.7K | −0.9%105.7K after | |
| Jan 6, 2026 (view filing) | Jan 2 | 4 days | Kuriakose EmilChief Medical Officer | SSale | −1.16K | $38.57 | −$44.6K | −2.2%50.4K after | 2 lots |
| Oct 2, 2025 (view filing) | Oct 1 | 1 day | Kuriakose EmilChief Medical Officer | SSale | −944 | $7.85 | −$7.41K | −1.8%51.5K after | |
| Jul 3, 2025 (view filing) | Jul 1 | 2 days | Kuriakose EmilChief Medical Officer | SSale | −853 | $4.27 | −$3.64K | −1.6%52.5K after | |
| Apr 2, 2025 (view filing) | Apr 1 | 1 day | Kuriakose EmilChief Medical Officer | SSale | −952 | $2.49 | −$2.37K | −1.8%53.3K after | |
| Jan 6, 2025 (view filing) | Jan 2 | 4 days | Kuriakose EmilChief Medical Officer | SSale | −4.48K | $5.71 | −$25.6K | −7.6%54.3K after |